Increased exercise tolerance in humanized G6PD-deficient mice
Key PointsG6PD-deficient mice maintain higher exercise speeds without increased red blood cell hemolysis, questioning assumed risks.Increased cardiac outpu
Related Articles
IMM-1-104 Plus Chemo Generates Responses in First-Line Pancreatic Cancer
First-line IMM-1-104 plus chemotherapy produced responses and disease control in patients with pancreatic cancer.
Mobile Lung Screening
Moffitt is taking lung screenings on the road with our new mobile low-dose CT scan, ensuring easy access for eligible individuals in Florida.
How to stay active when you don’t feel your best
It can be difficult to stay active, especially when you aren’t feeling your best. Here, our experts share seven tips for balancing activity and rest…
Evolutionary cell biologist Dr. Grant King named a Hanna Gray Fellow
The Howard Hughes Medical Institute has named Fred Hutch Cancer Center postdoctoral researcher Grant King, PhD, a Hanna H. Gray Fellow — investing up to…
Welcome! You are invited to join a webinar: SSO CGSO Videoconference: Melanoma. After registering, you will receive a confirmation email about joining the webinar.
SSO sponsors educational videoconferences for CGSO Fellows, Residents, and faculty. This session will discuss the management of melanoma in both the localized and metastatic setting.…
Health Canada Green Lights Fruquintinib for Metastatic Colorectal Cancer
Health Canada approved fruquintinib for select patients with metastatic colorectal cancer.
OncLive – Clinical Oncology News, Cancer Expert Insights
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Adjuvant Multi-Agent Chemotherapy Extends OS in Pancreatic Cancer – Oncology Nurse Advisor
Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.
FDA Grants Breakthrough Device Designation to DCISionRT for Breast Cancer With DCIS
The FDA has granted a breakthrough device designation to the DCISionRT test for patients with breast cancer with ductal carcinoma in situ.
Collection Details : Oncology Times
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
